Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;57(8):3291-3306.
doi: 10.1007/s12035-020-01972-9. Epub 2020 Jun 8.

Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling

Amany El-Shahawy Abdel-Maged  1 , Amany M Gad  2 , Laila Ahmed Rashed  3 , Samar S Azab  4 , Eman A Mohamed  5 , Azza S Awad  5
Affiliations

Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling

Amany El-Shahawy Abdel-Maged et al. Mol Neurobiol. 2020 Aug.

Abstract

Multiple sclerosis (MS) is a chronic, inflammatory, and neurodegenerative autoimmune disease. MS is a devastating disorder that is characterized by cognitive and motor deficits. Cuprizone-induced demyelination is the most widely experimental model used for MS. Cuprizone is a copper chelator that is well characterized by microgliosis and astrogliosis and is reproducible for demyelination and remyelination. Secukinumab (SEC) is a fully human monoclonal anti-human antibody of the IgG1/kappa isotype that selectively targets IL-17A. Expression of IL-17 is associated with MS. Also, IL-17 stimulates microglia and astrocytes resulting in progression of MS through chemokine production and neutrophil recruitment. This study aimed to investigate the neuroprotective effects of SEC on cuprizone-induced demyelination with examining the underlying mechanisms. Locomotor activity, short-term spatial memory function, staining by Luxol Fast Blue, myelin basic protein, gliasosis, inflammatory, and oxidative-stress markers were assessed to evaluate neuroprotective, anti-inflammatory and antioxidant effects. Moreover, the safety profile of SEC was evaluated. The present study concludes the efficacy of SEC in Cup-induced demyelination experimental model. Interestingly, SEC had neuroprotective and antioxidant effects besides its anti-inflammatory effect in the studied experimental model of MS. Graphical abstract.

Keywords: Cuprizone; Immune response; Multiple sclerosis; Secukinumab.

PubMed Disclaimer

References

    1. Ohl K, Tenbrock K, Kipp M (2016) Oxidative stress in multiple sclerosis: central and peripheral mode of action. Exp Neurol 277:58–67 - PubMed
    1. McDonnell GV, Hawkins SA (1996) Primary progressive multiple sclerosis: a distinct syndrome? Mult Scler J 2(3):137–141
    1. Thompson AJ et al (1997) Primary progressive multiple sclerosis. Brain 120(6):1085–1096 - PubMed
    1. Duquette P, Pleines J, Girard M, Charest L, Senecal-Quevillon M, Masse C (2015) The increased susceptibility of women to multiple sclerosis. Can J Neurol Sci 19(4):466–471
    1. Stadelmann C, Wegner C, Bruck W (2011) Inflammation, demyelination, and degeneration—recent insights from MS pathology. Biochim Biophys Acta 1812(2):275–282 - PubMed

MeSH terms

LinkOut - more resources